Alterity Therapeutics to join Cantor Global Healthcare conference fireside chat
Alterity Therapeutics said David Stamler will participate in a fireside chat at the Cantor Global Healthcare Conference 2026.
MELBOURNE, Australia and SAN FRANCISCO, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M…